Effect of Dexmedetomidine on the Prevention of Emergence Agitation in Children Undergoing Day Surgery

NACompletedINTERVENTIONAL
Enrollment

389

Participants

Timeline

Start Date

September 18, 2017

Primary Completion Date

May 15, 2019

Study Completion Date

May 21, 2019

Conditions
Ambulatory Surgical Procedures
Interventions
DRUG

0.2ug/kg dexmedetomidine

subjects were randomly assigned to receive 0.2ug/kg intravenous dexmedetomidine before skin incision

DRUG

0.4ug/kg dexmedetomidine

subjects were randomly assigned to receive 0.4ug/kg intravenous dexmedetomidine before skin incision

DRUG

0.6ug/kg dexmedetomidine

subjects were randomly assigned to receive 0.6ug/kg intravenous dexmedetomidine before skin incision

DRUG

0.8ug/kg dexmedetomidine

subjects were randomly assigned to receive 0.8ug/kg intravenous dexmedetomidine before skin incision

DRUG

1.0ug/kg dexmedetomidine

subjects were randomly assigned to receive 1.0ug/kg intravenous dexmedetomidine before skin incision

Trial Locations (1)

510000

Guangzhou Women and Children Medical Center, Guangzhou

All Listed Sponsors
lead

Guangzhou Women and Children's Medical Center

OTHER

NCT03262090 - Effect of Dexmedetomidine on the Prevention of Emergence Agitation in Children Undergoing Day Surgery | Biotech Hunter | Biotech Hunter